Dr. Kay and his colleagues have accumulated a large database of both clinical information and tissue samples (such as blood and marrow) from CLL patients. The latter effort is able to collect valuable information on critical biologic and prognostic features of CLL patients that can be correlated with their clinical outcomes. The work that stems from this database provides information on strategies for unique therapies.